(Q39426735)

English

Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

cell differentiation

1 reference

based on heuristic

inferred from title

Corynebacterium pyruviciproducens

object named as

Corynebacterium pyruviciproducens

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Han Qingzhen

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tong Jia

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wang Shengjun

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zhao Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Liu Yanfang

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shen Pei

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Baidoo Samuel Essien

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Su Zhaoliang

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xia Sheng

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shao Qixiang

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S M Finegold

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Huaxi Xu

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

14 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1115-1123

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The introduction of multi-copy CpG motifs into an antiviral DNA vaccine strongly up-regulates its immunogenicity in fish

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Non-cell Corynebacterium parvum generated by nanotechnology: a promising immunomodulator with less side effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Corynebacterium pyruviciproducens sp. nov., a pyruvic acid producer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Anticancer Potential of Aqueous Ethanol Seed Extract of Ziziphus mauritiana against Cancer Cell Lines and Ehrlich Ascites Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Immunology of TLR-independent vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Overview of vaccine adjuvants: present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Dendritic Cell Maturation Controls Adhesion, Synapse Formation, and the Duration of the Interactions with Naive T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Antigen presenting cells in mucosal sites of veterinary species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Pulmonary dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

IL-6 Production by Pulmonary Dendritic Cells Impedes Th1 Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Modulation of the type I hypersensitivity late phase reaction to OVA by Propionibacterium acnes-soluble polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Development of novel lipidated analogs of picroside as vaccine adjuvants: acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Key structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: Chemical synthesis and functional studies"

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.005

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.12.005

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39426735&oldid=1826946722"